Jonathan Solomon is the founder of BIOMx. BIOMx has raised $12M in total funding. Latest round: Series B. Based in Gaithersburg, Maryland, United States.
Jonathan Solomon is the CEO of BiomX, a microbiome company specializing in developing customized phage therapies. The company focuses on targeting harmful bacteria in chronic diseases like inflammatory bowel disease (IBD) and cancer. BiomX successfully raised $32 million in a Series B financing round, with plans to advance its drug candidates for acne and IBD into clinical trials. Solomon's leadership aims to transition BiomX into a clinical-stage company.
Full founder directory · Investor directory · Company funding database · Fundraising library